Purdue Pharma’s Creditors Overwhelmingly Endorse Bankruptcy Plan
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help cover costs from the opioid epidemic.
View original article
Contributor: Jan Hoffman
